Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by G. Hechmati
PCN9 Modeling Lifetime Effectiveness of Denosumab Versus Placebo in Men With Castration Resistant Prostate Cancer (CRPC) at High Risk of Developing Bone Metastasis (BM)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PCN115 Cost of Skeletal-Related Events (SREs) in Patients With Bone Metastases to Solid Tumours Based on the Health Resource Utilisation (HRU) Collected in a Prospective European Multinational Observational Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Pcn153 - Cost-Effectiveness Analysis of Apalutamide for Treatment in Non- Metastasis Castration-Resistant Prostate Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Severe Hypocalcemia Associated With Denosumab in Metastatic Castration-Resistant Prostate Cancer: Risk Factors and Precautions for Treating Physicians
Clinical Genitourinary Cancer
Oncology
Urology
Guideline Adherence in Docetaxel Treatment of Castration Resistant Prostate Cancer (CRPC) Patients in a Real-World Population: The Castration Resistant Prostate Cancer Registry (CAPRI) in the Netherlands
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Structure−Activity Relationship for Thiohydantoin Androgen Receptor Antagonists for Castration-Resistant Prostate Cancer (CRPC)
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Quantitative Measurement of 219Rn Radioactivity in Exhaled Breath From Patients With Bone Metastasis of Castration-Resistant Prostate Cancer Treated With 223RaCl2
EJNMMI Physics
Instrumentation
Nuclear Medicine
Radiology
Radiation
Imaging
Biomedical Engineering
Association Between New Unconfirmed Bone Lesions and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide
JAMA Oncology
Cancer Research
Oncology
Treatment of Castration-Resistant Prostate Cancer and Bone Metastases With Radium-223 Dichloride
International Journal of Urological Nursing
Urology
Nursing
Nephrology
Docetaxel and Dasatinib or Placebo in Men With Metastatic Castration-Resistant Prostate Cancer (READY): A Randomised, Double-Blind Phase 3 Trial
The Lancet Oncology
Oncology
A Phase I Study of Niclosamide in Combination With Enzalutamide in Men With Castration-Resistant Prostate Cancer
PLoS ONE
Multidisciplinary
